Your browser doesn't support javascript.
loading
Recent Insights Into Mechanisms and Clinical Approaches to Electrical Storm.
Elsokkari, Ihab; Tsuji, Yukiomi; Sapp, John L; Nattel, Stanley.
Affiliation
  • Elsokkari I; University of Sydney, Nepean Blue Mountains Local Health District, Sydney, Australia.
  • Tsuji Y; Department of Physiology of Visceral Function, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Sapp JL; Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada. Electronic address: John.sapp@nshealth.ca.
  • Nattel S; Departments of Medicine and Research Center, Montreal Heart Institute and Université de Montréal and Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada; Institute of Pharmacology, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany; IHU LIYRC I
Can J Cardiol ; 38(4): 439-453, 2022 04.
Article in En | MEDLINE | ID: mdl-34979281
Electrical storm, characterized by repetitive ventricular tachycardia/ventricular fibrillation over a short period, is becoming more common with widespread use of implantable cardioverter defibrillator (ICD) therapy. Electrical storm, sometimes called "arrhythmic storm" or "ventricular tachycardia storm," is usually a medical emergency requiring hospitalization and expert management, and significantly affects short- and long-term outcomes. This syndrome typically occurs in patients with underlying structural heart disease (ischemic or nonischemic cardiomyopathy) or inherited channelopathies. Triggers for electrical storm should be sought but are often unidentifiable. Initial management is dictated by the hemodynamic status, whereas subsequent management typically involves ICD interrogation and reprogramming to reduce recurrent shocks, identification and management of triggers like electrolyte abnormalities, myocardial ischemia, or decompensated heart failure, and antiarrhythmic drug therapy or catheter ablation. Sympathetic nervous system activation is central to the initiation and maintenance of arrhythmic storm, so autonomic modulation is a cornerstone of management. Sympathetic inhibition can be achieved with medications (particularly ß-adrenoreceptor blockers), deep sedation, or cardiac sympathetic denervation. More definitive management targets the underlying ventricular arrhythmia substrate to terminate and prevent recurrent arrhythmia. Arrhythmia targeting can be achieved with antiarrhythmic medications, catheter ablation, or more novel therapies, such as stereotactic radiation therapy, that target the arrhythmic substrate. Mechanistic studies point to adrenergic activation and other direct consequences of ICD shocks in promoting further arrhythmogenesis and hypocontractility. In this report, we review the pathophysiologic mechanisms, clinical features, prognosis, and therapeutic options for electrical storm. We also outline a clinical approach to this challenging and complex condition, along with its mechanistic basis.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tachycardia, Ventricular / Defibrillators, Implantable / Catheter Ablation Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Can J Cardiol Journal subject: CARDIOLOGIA Year: 2022 Document type: Article Affiliation country: Australia Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tachycardia, Ventricular / Defibrillators, Implantable / Catheter Ablation Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Can J Cardiol Journal subject: CARDIOLOGIA Year: 2022 Document type: Article Affiliation country: Australia Country of publication: United kingdom